Maarten L. Zandvliet
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study.
Journal: The Lancet. Haematology
Published: March 02, 2026
Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection Model.
Journal: The Journal of infectious diseases
Published: March 19, 2018
Understanding clinical development of chimeric antigen receptor T cell therapies.
Journal: Cytotherapy
Published: January 31, 2017
Clinical development of gene- and cell-based therapies: overview of the European landscape.
Journal: Molecular therapy. Methods & clinical development
Published: July 19, 2016
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 21, 2016
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.
Journal: British journal of clinical pharmacology
Published: May 10, 2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.
Journal: Oncotarget
Published: April 19, 2016
Development of cell therapy medicinal products by academic institutes.
Journal: Drug discovery today
Published: February 02, 2016
Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
Journal: Journal of translational medicine
Published: September 01, 2015
Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 22, 2012
Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: February 07, 2012
Last Updated: 09/26/2026